<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Seven secondary <z:hpo ids='HP_0001909'>leukemia</z:hpo> patients were treated for <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> or malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with anticancer drugs or radiation </plain></SENT>
<SENT sid="1" pm="."><plain>We studied bone marrow samples from these patients by fluorescence in situ hybridization (FISH) </plain></SENT>
<SENT sid="2" pm="."><plain>Of the seven patients, three had increased signals for the ABL oncogene (9q34) on interphase nuclei and at metaphase </plain></SENT>
<SENT sid="3" pm="."><plain>One of the three patients also had four signals for the CD3 (MLL) region (11q23) </plain></SENT>
<SENT sid="4" pm="."><plain>Whole painting probes revealed that these chromosomal regions were translocated onto structurally abnormal chromosomes, resulting in partial tri-, tetra- or penta-somy of these regions </plain></SENT>
<SENT sid="5" pm="."><plain>We called this type of translocation "segmental jumping translocation (SJT)." SJT of the ABL oncogene was not detected in samples from 15 patients with de novo <z:hpo ids='HP_0004808'>acute myelocytic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), 12 with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), or 20 with <z:hpo ids='HP_0011010'>chronic</z:hpo> myelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) at the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, <z:mp ids='MP_0004026'>monosomy</z:mp> 7 was also found in the patients with the gene amplification </plain></SENT>
<SENT sid="7" pm="."><plain>These results indicate that SJT of ABL and/or CD3 (MLL) genes is associated with the <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> of secondary <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The SJT may be one mechanism of gene amplification </plain></SENT>
</text></document>